Drug · DIN 02500337
ODOMZO
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 24, 2026; first marketed December 23, 2020.
- Drug Identification Number (DIN)
- 02500337
- Company (DIN owner)
- Sun Pharmaceutical Industries LimitedMumbai, Maharashtra, India
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Sonidegib L01XJ02
- Class
- Human
- Record last updated
- June 16, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SONIDEGIB (SONIDEGIB PHOSPHATE) | 200 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 4, 2022: NOC 27329New Drug Submission (NDS) · Administrative: Merger/Buy-out
- June 12, 2020: NOC 23772New Drug Submission (NDS)